Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 301, Issue 1, 2003, Pages 78-83

  Ohkawa, Yasuyuki ^a   Hayashi, Ken'ichiro ^a   Sobue, Kenji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcineurin; Caldesmon; Phenotypic modulation; Protein kinase B; Smooth muscle cells; 1 Integrin

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CALDESMON; CYCLOSPORIN A; INTEGRIN; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; TACROLIMUS;

ANIMAL CELL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CHICKEN; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; GENE FUNCTION; GENE REPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VISCERA;

EID: 0037474452     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02965-0     Document Type: Article

References (25)

1. Olson E.N., Williams R.S. Remodeling muscles with calcineurin. BioEssays. 22:2000;510-519.
2. Graef I.A., Chen F., Crabtree G.R. NFAT signaling in vertebrate development. Curr. Opin. Genet. Dev. 11:2001;505-512.
3. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
4. Goldspink P.H., McKinney R.D., Kimball V.A., Geenen D.L., Buttrick P.M. Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats. Mol. Cell. Biochem. 226:2001;83-88.
5. Friday B.B., Horsley V., Pavlath G.K. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J. Cell Biol. 149:2000;657-666.
6. 2+ -dependent calcineurin signaling pathway Nature. 400:1999;576-581.
7. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature. 400:1999;581-585.
8. Horsley V., Friday B.B., Matteson S., Kegley K.M., Gephart J., Pavlath G.K. Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153:2001;329-338.
9. Mitchell P.O., Mills S.T., Pavlath G.K. Calcineurin differentially regulates maintenance and growth of phenotypically distinct muscles. Am. J. Physiol. Cell Physiol. 282:2002;C984-992.
10. 2+ /calcineurin and NFATc3/c4 pattern the developing vasculature Cell. 105:2001;863-875.
11. Wada H., Hasegawa K., Morimoto T., Kakita T., Yanazume T., Abe M., Sasayama S. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J. Cell Biol. 156:2002;983-991.
12. Sobue K., Hayashi K., Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol. Cell. Biochem. 190:1999;105-118.
13. Yamanaka Y., Hayashi K., Komurasaki T., Morimoto S., Ogihara T., Sobue K. EGF family ligand-dependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem. Biophys. Res. Commun. 281:2001;373-377.
14. Hayashi K., Saga H., Chimori Y., Kimura K., Yamanaka Y., Sobue K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J. Biol. Chem. 273:1998;28860-28867.
15. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J. Cell Biol. 145:1999;727-740.
16. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A., Aoki J., Arai H., Sobue K. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89:2001;251-258.
17. Obata H., Hayashi K., Nishida W., Momiyama T., Uchida A., Ochi T., Sobue K. Smooth muscle cell phenotype-dependent transcriptional regulation of the. α 1 integrin gene J. Biol. Chem. 272:1997;26643-26651.
18. Yano H., Hayashi K., Momiyama T., Saga H., Haruna M., Sobue K. Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J. Biol. Chem. 270:1995;23661-23666.
19. Nishida W., Nakamura M., Mori S., Takahashi M., Ohkawa Y., Tadokoro S., Yoshida K., Hiwada K., Hayashi K., Sobue K. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J. Biol. Chem. 277:2002;7308-7317.
20. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 23:1996;6541-6551.
21. Saga H., Kimura K., Hayashi K., Gotow T., Uchiyama Y., Momiyama T., Tadokoro S., Kawashima N., Jimbou A., Sobue K. Phenotype-dependent expression of. α -smooth muscle actin in visceral smooth muscle cells Exp. Cell Res. 247:1999;279-292.
22. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., Shimbo T., Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 397:1999;530-534.
23. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science. 275:1997;1930-1934.
24. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
25. Nakamura M., Nishida W., Mori S., Hiwada K., Hayashi K., Sobue K. Transcriptional activation of. β -tropomyosin mediated by serum response factor and a novel Barx homologue, Barx1b, in smooth muscle cells J. Biol. Chem. 276:2001;18313-18320.